Neurological Biomarkers Market worth $9.91 billion by 2030
The report "Neurological Biomarkers Market by Offering (Consumables, Instruments), Type (Proteomic, Genomic), Application (Alzheimer’s, Parkinson’s), End user (Pharma Companies, Clinical Labs) -Global Forecast to 2030", is projected to reach USD 9.91 billion by 2030 from USD 5.53 billion in 2025, at a CAGR of 10.7% during the forecast period.
Browse 370 market data Tables and 39 Figures spread through 300 Pages and in-depth TOC on "Neurological Biomarkers Market by Offering (Consumables, Instruments), Type (Proteomic, Genomic), Application (Alzheimer’s, Parkinson’s), End user (Pharma Companies, Clinical Labs) -Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/neurological-biomarkers-market-153432005.html
The neurological biomarkers market is experiencing growth, driven by several key factors, including the rising prevalence of neurological disorders and increased clinical and regulatory recognition.
The genomic biomarkers segment will be the fastest-growing, by type, during the forecast period.
Genomic biomarkers represent one of the fastest-growing segments in the neurological biomarkers market, fueled by expanding NGS adoption, lower sequencing costs, precision neurology approaches, improved risk stratification, and greater integration into drug development, diagnostics, and clinical trial patient selection.
In 2024, the pharmaceutical & biotechnology companies segment had the largest market share, by end user.
Pharmaceutical and biotechnology companies held the largest share of the neurological biomarkers end-user segment, driven by their extensive reliance on biomarkers for drug discovery, target validation, patient stratification, and companion diagnostics. Growing investments in precision neurology, expanding neurological drug pipelines, and increased use of biomarker-driven clinical trials further strengthened adoption across preclinical and clinical development stages.
North America accounted for the largest regional share in the neurological biomarkers market in 2024.
The market is segmented into North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. North America accounted for the largest share of the neurological biomarkers market, driven by advanced healthcare infrastructure, a strong presence of leading pharmaceutical and biotechnology companies, high R&D spending, early adoption of precision medicine, and supportive regulatory frameworks that enable rapid biomarker development and commercialization.
Key players in the neurological biomarkers market include Abbott (US), Thermo Fisher Scientific Inc. (US), QIAGEN (Germany), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), Johnson & Johnson (US), Quanterix (US), and Banyan Biomarkers, Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Neurological Biomarkers Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
